FDA Inspection 1193134 — Atlanta Blood Services

Atlanta Blood Services — FEI 3001739811

The FDA completed an inspection of Atlanta Blood Services on November 11, 2022 in Atlanta, GA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
November 11, 2022
Fiscal Year
2023
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Atlanta, GA (United States)